Evidence map›Paper›PMID 40846344›Full record

ArticleBMJ global health2025

Integrating secondary prevention of rheumatic heart disease into the primary healthcare system in Northern Uganda.

Neema W Minja, Jafesi Pulle, Joselyn Rwebembera, Nicholas J Ollberding, Ndate Fall, Jenifer Atala, Jenipher Kamarembo, Linda Oyella, Francis Odong, Sarah R de Loizaga and 9 more

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Neema W MinjaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Jafesi PulleRRCU, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.ORCID 0000-0001-7955-3481
Joselyn RwebemberaDepartment of Cardiology, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.
Nicholas J OllberdingDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Ndate FallThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Jenifer AtalaRRCU, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.
Jenipher KamaremboRRCU, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.
Linda OyellaRRCU, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.
Francis OdongRRCU, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.
Sarah R de LoizagaThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0002-1001-273X
Doreen NakagaayiDepartment of Cardiology, Uganda Heart institute, Mulago Hospital, Kampala, Uganda.
Rachel SarnackiChildren's National Medical Center, Seattle, Washington, USA.
Judith W DexheimerDepartment of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Craig SableChildren's National Medical Center, Seattle, Washington, USA.
Chris T LongeneckerDepartment of Global Health & Division of Cardiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-9468-0179
Emmy OkelloDepartment of Medicine, College of Health Science, Makerere University, Kampala, Uganda.
Andrea Z BeatonThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
David A WatkinsDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-6341-9595
Kristen M DanforthDepartment of Global Health, University of Washington, Seattle, Washington, USA danfortk@uw.edu.ORCID 0000-0002-7409-6661

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
NCATS NIH HHS UL1 TR002548
6 · The paper itself

Abstract

introductionOver 46 million people are living with rheumatic heart disease (RHD) globally, resulting in 380 000 premature deaths each year. Effective RHD prevention strategies are known but their implementation in low-resource settings has lagged. This study evaluated the feasibility and effectiveness of integrating secondary antibiotic prophylaxis into primary health centres to improve access and adherence to RHD care.

methodsWe conducted a hybrid type III study using a mixed-method, pre-post design to evaluate a package of implementation strategies centred on decentralised RHD care and use of an electronic medical record in Gulu and Lira, Uganda. We combined clinical and programmatic data with provider and patient interviews to assess effectiveness, adoption and acceptability. The mean difference in the annualised percentage of days adherent to benzathine penicillin G (BPG) monthly injections predecentralisation and postdecentralisation was calculated using linear mixed effect regression. Thematic analysis was used to analyse qualitative data.

resultsWe decentralised 151 patients (median age 17.9 years, 64% female) from district hospitals to eight primary health centres. The percentage of days adherent to BPG was 77.2% predecentralisation and 80.5% postdecentralisation (mean difference 3.25, (95% CI -0.72 to 6.86), p=0.081), which was statistically non-inferior at the -10% non-inferiority margin. Interview data identified knowledge, confidence and intrinsic motivation as major determinants of provider adoption. Patients expressed mixed feelings towards pain control and provider services, but convenience and financial savings resulted in a high level of acceptability. The electronic registry presented challenges in a naive environment but showed a strong potential as an oversight tool at the district level. DISCUSSION: This study is the first to demonstrate that decentralised RHD care is effective in sub-Saharan Africa. Lessons learnt provide a platform for future integration of RHD services countrywide, with implications for increasing access to and scale-up of secondary prevention measures for RHD care in Uganda.

Indexed as

Anti-Bacterial AgentsAntibiotic ProphylaxisPenicillin G BenzathinePrimary Health CareRheumatic Heart DiseaseSecondary PreventionAdolescentAdultChildFemaleHumansMaleUgandaYoung AdultAnti-Bacterial AgentsPenicillin G BenzathineGlobal HealthHealth systems

Identifiers

PMID40846344
PMCPMC12374643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.